Nightfood Subsidiary TechForce Deploys Autonomous Lab Robot, Marking Expansion into Pharmaceutical Automation

Nightfood Holdings Inc. (OTCQB: NGTF) announced that its subsidiary, TechForce Robotics, has successfully completed Phase 1 objectives under its joint development agreement with Oncotelic Therapeutics (OTCQB: OTLC), highlighted by the initial deployment of LIM-E, an autonomous laboratory support robot. This deployment marks TechForce’s first expansion into pharmaceutical and laboratory automation and validates the adaptability of its AI-enhanced robotics platform beyond hospitality and service-industry applications into life sciences and pharmaceutical environments.

TechForce said the deployment completed the initial operational goals established under the companies’ April 2026 collaboration agreement and will provide operational data and workflow insights to support future automation initiatives. The companies plan to continue evaluating opportunities in laboratory logistics, manufacturing support, AI-enhanced workflows and other automation applications, while Nightfood views healthcare, life sciences and pharmaceutical manufacturing as significant long-term growth markets for its Robotics-as-a-Service platform.

According to the press release, the deployment is a milestone for TechForce, which originally focused on hospitality and foodservice robotics. The company’s RaaS model allows clients to access autonomous systems without large upfront capital expenditures, making automation more accessible. The partnership with Oncotelic Therapeutics, a clinical-stage biopharmaceutical company, provides a real-world testing environment for LIM-E, which is designed to handle repetitive tasks such as transporting lab materials, restocking supplies, and assisting with sample management.

The implications of this announcement extend beyond the two companies. As pharmaceutical and laboratory settings face increasing pressure to improve efficiency and reduce human error, autonomous robots like LIM-E could become integral to workflows. TechForce’s successful deployment demonstrates that its technology can be adapted to highly regulated environments, potentially opening doors to contracts with other biotech and pharmaceutical firms. For Nightfood Holdings, this represents a strategic pivot toward higher-margin, long-term growth sectors.

Nightfood Holdings, Inc. (dba TechForce Robotics) is focused on the development, integration, and deployment of AI-enhanced automation solutions across multiple commercial industries. Through its TechForce Robotics platform, the Company develops and deploys autonomous robotic systems designed to improve operational efficiency, workflow consistency, and scalability across hospitality, foodservice, commercial, laboratory, and emerging enterprise automation environments. The Company combines advanced hardware, intelligent AI-enhanced software, and scalable operational infrastructure to support long-term growth through its Robotics-as-a-Service (RaaS) model.

For more information, visit the company’s newsroom at http://ibn.fm/NGTF. The full press release is available at https://ibn.fm/RFkfL.